Muira Puama for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Muira Puama for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

An Amazonian root and bark preparation long used as a sexual tonic and a remedy for nervous exhaustion. Laboratory work touches brain chemistry and blood-vessel relaxation, but the herb alone has never been tested against a placebo in people. Side effects reported so far are mild. The dominant hazard is hidden prescription drugs in this product category. (Full Review)

Protocol

Standard extract dose
1,000–1,500 mg daily
4:1 concentrated extract, roughly 4–6 g of crude root and bark. Older adults are reasonably started at 500–1,000 mg.
Preparation matters
Alcohol-based extract
Active constituents are fat-soluble, so water infusions extract them poorly. Tinctures and hydroalcoholic dry extracts were used in every reported study.
Best time of day
Morning or early afternoon
Given the stimulant profile. For episodic sexual use, roughly 60–90 minutes before activity is common practice, though no timing study supports it.
Time to effect
Sexual desire & erection
2 weeks
Uncontrolled series reported changes within two weeks; a realistic assessment window is 8–12 weeks.
Burning mouth symptoms
4–12 weeks
Symptom scores fell further than placebo from four weeks onward, tested only as a four-herb formula.
Artery dilation
14 days
Twice-daily dosing of a four-ingredient formula; results registry-stated and still unpublished.

Benefits

Contraindications
  • Pregnancy and lactation
  • Anyone under 18 years of age
  • Nitrates for angina, or within 90 days of myocardial infarction (heart attack)
  • New York Heart Association Class III–IV heart failure (marked limitation of activity, or symptoms at rest)
  • Child-Pugh Class B or C liver impairment (moderate to severe)
  • Active or prior hormone-sensitive cancer (breast, uterine, prostate)
  • Uncontrolled anxiety disorder or chronic insomnia
  • Known hypersensitivity to muira puama or other Olacaceae family plants
    •
Key Interactions
  • Phosphodiesterase-5 inhibitors (sildenafil, tadalafil, vardenafil)
  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)
  • Anticholinergic drugs (oxybutynin, benztropine, sedating antihistamines)
  • Antihypertensives (amlodipine, lisinopril, doxazosin)
  • Monoamine oxidase inhibitors (phenelzine, tranylcypromine)
  • Over-the-counter stimulants and alcohol
  • Nitric-oxide-boosting supplements (L-Citrulline, L-Arginine, beetroot nitrate, Pycnogenol)
  • Cholinesterase-inhibiting botanicals (huperzine A, Bacopa monnieri, galantamine-containing extracts)
  • Yohimbine and Panax ginseng
  • Other interventions (testosterone therapy, low-intensity shockwave therapy)
    •

Risk & Side Effects

  • High: Undisclosed pharmaceutical adulterants in marketed products
  • Medium: Gastrointestinal upset and headache
    •
  • Low: Central nervous system overstimulation
    •
  • Speculative: Additive cholinergic effects; estrogen-receptor activity

Monitoring

Marker Target Why
Total testosterone 600–900 ng/dL (men) Shows whether low desire is hormonal rather than herb-responsive
Free testosterone 15–25 ng/dL (men) The fraction actually available to tissue receptors
Estradiol, sensitive assay 20–30 pg/mL (men) Baseline for the herb's predicted estrogen-receptor activity
SHBG 20–40 nmol/L High values lock up testosterone and mimic deficiency
ALT 10–26 U/L Catches liver strain from a metabolically uncharacterised botanical
hs-CRP Below 1.0 mg/L Tracks the inflammatory background the antioxidant claim targets
Resting blood pressure Below 120/80 mmHg Both the nitric-oxide claim and the adulteration hazard act here

Cadence: Blood pressure and symptoms at two weeks; full panel and questionnaire at eight weeks; then every 6–12 months for long-term use.

Qualitative Assessment

  • Frequency and intensity of sexual desire, tracked weekly rather than recalled
  • Erection quality and reliability, scored on the International Index of Erectile Function at baseline and week eight
  • Daytime fatigue and physical stamina
  • Sleep onset latency and night-time waking, the earliest signals of overstimulation
  • Subjective tension, restlessness or irritability
  • Cognitive clarity and word-finding, given the cholinergic mechanism
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.